Mefenamic Acid Dosing for 14-Year-Old with Dysmenorrhea
For a 14-year-old with dysmenorrhea, prescribe mefenamic acid 500 mg as an initial loading dose, followed by 250 mg every 6 hours, starting at the onset of menstrual bleeding or pain (whichever comes first), for a maximum of 2-3 days per cycle.
Dosing Regimen
The FDA-approved indication for mefenamic acid includes treatment of primary dysmenorrhea in patients ≥14 years of age 1. The specific dosing protocol is:
- Loading dose: 500 mg (2 capsules) at onset
- Maintenance: 250 mg every 6 hours thereafter
- Duration: Maximum 3 days per menstrual cycle
- Maximum daily dose: 2000 mg (4 × 500 mg) 2, 3
Start medication at the very first sign of menstrual bleeding or pain, whichever begins first 1. This timing is critical for optimal efficacy.
Evidence Base
Clinical trials demonstrate that mefenamic acid with this regimen provides complete relief of dysmenorrhea symptoms in approximately 88.6% of patients across all treated cycles 4. The drug was significantly superior to placebo in all parameters including pain assessment, need for concurrent analgesics, and reduction in frequency/severity of dysmenorrhea symptoms 1.
Practical Considerations
Available formulation: 250 mg capsules 2, 3
Treatment duration: Limit therapy to one week (7 days) maximum per the FDA indication 1. For dysmenorrhea, this translates to 2-3 days of actual use per menstrual cycle, which is well within safety parameters.
Timing strategy: Instruct the patient to begin taking mefenamic acid either:
- When menstrual bleeding starts, OR
- When pain begins (if pain precedes bleeding)
Safety Profile
Mefenamic acid is generally well-tolerated in adolescents. The most common side effects are gastrointestinal (nausea, GI discomfort), though these occur less frequently than with some alternatives 5. Gastric protection is recommended if NSAIDs are used over prolonged periods 3, though short-term cyclical use for dysmenorrhea typically doesn't require this.
Common Pitfalls to Avoid
- Don't delay treatment: Starting medication after pain is well-established reduces efficacy
- Don't exceed 3 days per cycle: The FDA specifically limits treatment duration to avoid unnecessary NSAID exposure 1
- Don't use in patients with renal impairment: Mefenamic acid is contraindicated in pre-existing renal disease 1
- Ensure adequate hydration: NSAIDs carry renal toxicity risk, particularly important in adolescents
Alternative Consideration
If the patient experiences inadequate relief or GI side effects, ibuprofen (400-600 mg every 6-8 hours) represents an equally effective alternative with potentially better GI tolerability 6, 7.